MDA-MB-231 cells are aggressive, treatment-resistant triple-negative breast carcinoma (TNBC) cells that are essentially mesenchymal since the epithelial biomarker E-cadherin expression is transcriptionally repressed by methylation of the E-cadherin promoter. Here, CDH1 is linked to triple-negative breast carcinoma.